The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized comparisons of bevacizumab (B) and irinotecan (I), added to temozolomide (T), in children with relapsed or refractory high-risk neuroblastoma (RR-HRNB): First survival results of the ITCC-SIOPEN BEACON-Neuroblastoma phase II trial.
 
Keith Wheatley
Research Funding - Roche (Inst)
 
Grace Holt
No Relationships to Disclose
 
Cormac Owens
No Relationships to Disclose
 
Jennifer Laidler
No Relationships to Disclose
 
Dominique Valteau-Couanet
Consulting or Advisory Role - EUSA Pharma (Inst)
Research Funding - Orphelia Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Royalties from Apeiron to SIOPEN (Inst)
Travel, Accommodations, Expenses - EUSA Pharma; Jazz Pharmaceuticals
 
Marion Gambart
Consulting or Advisory Role - Bayer
Travel, Accommodations, Expenses - EUSA Pharma
 
Victoria Castel
No Relationships to Disclose
 
Natasha van Eijkelenburg
No Relationships to Disclose
 
Aurora Castellano
No Relationships to Disclose
 
Karsten Nysom
Honoraria - Bayer
Consulting or Advisory Role - Bayer
 
Nicolas U. Gerber
No Relationships to Disclose
 
Genevieve Laureys
No Relationships to Disclose
 
Ruth Lydia Ladenstein
Honoraria - Apeiron Biologics; Boehringer Ingelheim; EUSA Pharma
Consulting or Advisory Role - Apeiron Biologics; Boehringer Ingelheim; EUSA Pharma (Inst)
Research Funding - Apeiron Biologics (Inst); EUSA Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Apeiron Biologics (Inst); EUSA Pharma (Inst)
Expert Testimony - Apeiron Biologics; EUSA Pharma
Travel, Accommodations, Expenses - Apeiron Biologics; EUSA Pharma
 
Guy Makin
No Relationships to Disclose
 
Sucheta Vaidya
No Relationships to Disclose
 
Estelle Thebaud
No Relationships to Disclose
 
Pamela Kearns
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Genzyme
Research Funding - Pfizer (Inst)
 
Andrew DJ Pearson
Consulting or Advisory Role - Celgene; Lilly; Merck; Takeda
Travel, Accommodations, Expenses - Celgene; Lilly; Merck; Takeda
 
Lucas Moreno
Honoraria - Celgene; Novartis
Consulting or Advisory Role - Shionogi (Inst)
Patents, Royalties, Other Intellectual Property - Member of SIOPEN Executive Committee, SIOPEN receives royalties for the sales of dinutuximab beta (Inst)